Novartis AG

Postfach

4002 Basel

Switzerland

 

January 23, 2013

 

US Securities and Exchange Commission

100 F Street, N.E.

Washington, DC  20549

 

Re:                             Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

 

Dear Sirs:

 

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Novartis AG has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2012, which was filed with the Securities and Exchange Commission on January 23, 2013.

 

 

 

Respectfully submitted,

 

 

 

 

 

 

 

Novartis AG

 

 

 

 

 

 

 

 

 

 

 

/s/ FELIX R. EHRAT

 

/s/ ANDREAS BOHRER

 

Felix R. Ehrat

 

Andreas Bohrer

 

General Counsel

 

Authorized Signatory

 

Novartis Group